Acute Ischaemic Stroke and Thrombolytic Therapy

Acute ischaemic stroke (AIS) is a preventable and treatable disease with high mortality and morbidity, accounting for 80% of cerebrovascular events. Hypertension (HT), atrial fibrillation (AF) and diabetes mellitus (DM) are risk factors in AIS. The diagnosis is made by starting thrombolytics within the first 4.5 hours after anamnesis, neurological examination and exclusion of haemorrhage by computed tomography.